This list is an analysis based on recent market events. It's not an investment recommendation.
Pathkey.AI Ltd is an Australian digital health firm that harnesses artificial intelligence (AI) to advance clinical trials and improve the predictability of patient outcomes, particularly within Australia. The company presents a suite of AI-driven solutions: TrialKey, a sophisticated platform for simulating and optimizing trial designs to boost success rates, and TrialGen, an AI-powered utility crafted to simplify the clinical trial design process. They extend their services to a diverse clientele, encompassing biopharmaceutical companies, MedTech innovators, governmental agencies, and various healthcare organizations. Established in Sydney in 1994, the entity known today as Pathkey.AI Ltd will formally change its name from Opyl Limited in August 2025.
FAQs
What is Pathkey.AI stock price today?▼
The current price of W4O.F is €0.00 EUR — it has decreased by -99.5% in the past 24 hours. Watch Pathkey.AI stock price performance more closely on the chart.
What is Pathkey.AI stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Frankfurt Exchange exchange Pathkey.AI stocks are traded under the ticker W4O.F.
What is Pathkey.AI market cap?▼
Today Pathkey.AI has the market capitalization of 120,431.6
What is Pathkey.AI revenue for the last year?▼
Pathkey.AI revenue for the last year amounts to 26,892.65 EUR.
What is Pathkey.AI net income for the last year?▼
W4O.F net income for the last year is -2.19M EUR.
Does Pathkey.AI pay dividends?▼
Yes, W4O.F dividends are paid annual. The last dividend per share was 0.03 . As of today, Dividend Yield (FWD)% is 0%.
How many employees does Pathkey.AI have?▼
As of November 2, 2026, the company has 5 employees.
In which sector is Pathkey.AI located?▼
Pathkey.AI operates in the Health & Wellness sector.
When did Pathkey.AI complete a stock split?▼
Pathkey.AI has not had any recent stock splits.
Where is Pathkey.AI headquartered?▼
Pathkey.AI is headquartered in Sydney, Australia.